IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 190 filers reported holding IMMUNOGEN INC in Q2 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $239,000 | -18.7% | 36,300 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $294,000 | +149.2% | 36,300 | +98.4% | 0.01% | +75.0% |
| Q4 2020 | $118,000 | +140.8% | 18,300 | +35.6% | 0.00% | +33.3% |
| Q3 2020 | $49,000 | -21.0% | 13,500 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $62,000 | +34.8% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $46,000 | -9.8% | 13,500 | +35.0% | 0.00% | +33.3% |
| Q4 2019 | $51,000 | +112.5% | 10,000 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $24,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | -18.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $27,000 | -85.4% | 10,000 | -61.5% | 0.00% | 0.0% |
| Q2 2017 | $185,000 | +83.2% | 26,000 | 0.0% | 0.00% | – |
| Q1 2017 | $101,000 | +90.6% | 26,000 | 0.0% | 0.00% | – |
| Q4 2016 | $53,000 | -24.3% | 26,000 | 0.0% | 0.00% | – |
| Q3 2016 | $70,000 | -12.5% | 26,000 | 0.0% | 0.00% | – |
| Q2 2016 | $80,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |